{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:33:54Z","timestamp":1793223234814,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8257021693"],"award-info":[{"award-number":["8257021693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.atherosclerosis.2026.121927","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:15:31Z","timestamp":1791587731000},"page":"121927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ST3GAL1-mediated \u03b1-2,3 sialylation restrains CD105\u2013TGF\u03b2RII signaling to attenuate EndMT-driven atherosclerosis"],"prefix":"10.1016","volume":"422","author":[{"given":"Tianlan","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.121927_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib2","series-title":"Confronting the world's number one killer","year":"2023"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11892-019-1161-2","article-title":"Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors","volume":"19","author":"Jagannathan","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.651","article-title":"Endothelial dysfunction: molecular mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cvr\/cvab173","article-title":"Dietary recommendations for prevention of atherosclerosis","volume":"118","author":"Riccardi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib7","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.medcli.2020.04.024","article-title":"Atherosclerosis and inflammation. New therapeutic approaches","volume":"155","author":"Pedro-Botet","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib9","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1172\/JCI82719","article-title":"Endothelial-to-mesenchymal transition drives atherosclerosis progression","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5830\/CVJA-2011-068","article-title":"Endothelial dysfunction: the early predictor of atherosclerosis","volume":"23","author":"Mudau","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2353\/ajpath.2009.090698","article-title":"Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy","volume":"175","author":"Kizu","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cvr\/cvx253","article-title":"Endothelial-mesenchymal transition in atherosclerosis","volume":"114","author":"Souilhol","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11853","article-title":"Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability","volume":"7","author":"Evrard","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006927","article-title":"TGF-\u03b2 signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling","volume":"6","author":"Cooley","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.05.010","article-title":"Acetate controls endothelial-to-mesenchymal transition","volume":"35","author":"Zhu","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcvm.2020.00053","article-title":"Endothelial-to-Mesenchymal transition, vascular inflammation, and atherosclerosis","volume":"7","author":"Chen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/CIRCRESAHA.119.314813","article-title":"Endothelial-to-Mesenchymal transition","volume":"124","author":"Bischoff","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib18","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.3390\/ijms22094804","article-title":"Endoglin\/CD105-Based imaging of cancer and cardiovascular diseases: a systematic review","volume":"22","author":"Sier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41419-024-06546-4","article-title":"Endothelial Robo4 suppresses endothelial-to-mesenchymal transition induced by irradiation and improves hematopoietic reconstitution","volume":"15","author":"Adzraku","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molmed.2023.11.013","article-title":"Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction","volume":"30","author":"Ferro","year":"2024","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3390\/antiox10121947","article-title":"Oxygen-dependent changes in the N-Glycome of murine pulmonary endothelial cells","volume":"10","author":"Tiboldi","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/biomedicines14010021","article-title":"Galectin-3 and the glyco-inflammatory axis: a missing link to residual cardiovascular risk in coronary artery disease","volume":"14","author":"Otoda","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101498","article-title":"Hydrogen peroxide regulates endothelial surface N-glycoforms to control inflammatory monocyte rolling and adhesion","volume":"34","author":"McDonald","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib24","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1093\/eurheartj\/ehab347","article-title":"Neuraminidase 1 is a driver of experimental cardiac hypertrophy","volume":"42","author":"Chen","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/iub.2788","article-title":"N-acetylneuraminic acid modulates SQSTM1\/p62 sialyation-mediated ubiquitination degradation contributing to vascular endothelium dysfunction in experimental atherosclerosis mice","volume":"76","author":"Chen","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/glycob\/cwaa008","article-title":"The manifold roles of sialic acid for the biological functions of endothelial glycoproteins","volume":"30","author":"D'Addio","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/CIRCRESAHA.120.318124","article-title":"MIR503HG loss promotes endothelial-to-mesenchymal transition in vascular disease","volume":"128","author":"Monteiro","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1074\/jbc.274.2.584","article-title":"Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily","volume":"274","author":"Barbara","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/pr8008012","article-title":"Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry","volume":"8","author":"Chen","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13238-020-00741-7","article-title":"Role of glycosylation in TGF-\u03b2 signaling and epithelial-to-mesenchymal transition in cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41467-025-67563-1","article-title":"Loss of ALK4 promotes cancer progression through regulating TGF-\u03b2 receptor N-glycosylation","volume":"17","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12964-023-01060-0","article-title":"FUT2 inhibits the EMT and metastasis of colorectal cancer by increasing LRP1 fucosylation","volume":"21","author":"He","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib33","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014126","article-title":"Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells","volume":"296","author":"Britain","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216327","article-title":"CD105 in the progression and therapy of renal cell carcinoma","volume":"570","author":"Oladejo","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.1095","article-title":"Endoglin: an accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies","volume":"188","author":"Fonsatti","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib36","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2004-08-3308","article-title":"Thrombin induces endocytosis of endoglin and type-II TGF-Beta receptor and down-regulation of TGF-beta signaling in endothelial cells","volume":"105","author":"Tang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.20892\/j.issn.2095-3941.2019.0215","article-title":"Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGF\u03b21 pathways via off-VEGF signaling","volume":"17","author":"Zhang","year":"2020","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029948","article-title":"Structural and functional insights into endoglin ligand recognition and binding","volume":"7","author":"Alt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41467-025-67531-9","article-title":"Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment","volume":"17","author":"Guo","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107678","article-title":"An overview and future prospects of sialic acids","volume":"46","author":"Yang","year":"2021","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1550815","article-title":"Synergistic effects of mutation and glycosylation on disease progression","volume":"12","author":"Suzuki","year":"2025","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MOL.0000000000000461","article-title":"New insights into the role of glycosylation in lipoprotein metabolism","volume":"28","author":"van den Boogert","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101816","article-title":"Glycocalyx sialic acids regulate Nrf2-mediated signaling by fluid shear stress in human endothelial cells","volume":"38","author":"Psefteli","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev-biochem-032620-104745","article-title":"Endothelial glycocalyx turnover in vascular health and disease: rethinking endothelial dysfunction","volume":"94","author":"Gomez","year":"2025","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib47","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3390\/cells11192946","article-title":"Endothelial-to-Mesenchymal transition in atherosclerosis: friend or foe","volume":"11","author":"Gole","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib48","article-title":"Cancer cell-derived sialylated IgG interacting with Siglec-7\/9\/10 is a potential immunotherapeutic target in pancreatic cancer","volume":"7","author":"Zhang","year":"2026","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018756","article-title":"Neuraminidases 1 and 3 trigger atherosclerosis by desialylating low-density lipoproteins and increasing their uptake by macrophages","volume":"10","author":"Demina","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115774","article-title":"Sialic acid-siglec axis in human immune regulation, involvement in autoimmunity and cancer and potential therapeutic treatments","volume":"22","author":"Gianchecchi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib51","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.jtha.2023.06.007","article-title":"Novel vascular roles of human endoglin in pathophysiology","volume":"21","author":"Rossi","year":"2023","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2026.121927_bib52","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.7150\/ijms.115222","article-title":"Soluble endoglin reflects endothelial dysfunction in myocardial infarction patients: a retrospective observational study","volume":"22","author":"Rathouska","year":"2025","journal-title":"Int J Med Sci"}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2026.121930","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:03:42Z","timestamp":1793221422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026012931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":52,"alternative-id":["S0021915026012931"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121927","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ST3GAL1-mediated \u03b1-2,3 sialylation restrains CD105\u2013TGF\u03b2RII signaling to attenuate EndMT-driven atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121927"}}